Fabrice Egros has been appointed COO, pharmaceutical director and board member of NovaMedica. The business was established as part of the $760 million collaboration between the Russian high technology investment fund RUSNANO and the American health care venture fund Domain Associates.

Lilliputian Systems, Inc. said it closed on $40 million of a planned $60 million equity round that was led by RUSNANO and joined by existing investors Intel Corporation, Kleiner Perkins Caufield & Byers, Altira Group, Stata Venture Partners, Atlas Venture, and Fairhaven Capital. The company makes portable fuel cell re-charger for consumer electronics.

Quantenna Communications, Inc. said it raised $79 million in a round led by RUSNANO and joined by the new investor Bright Capital. Existing investors participated, including Sequoia Capital, DAG Ventures, Sigma Partners, Southern Cross Venture Partners and Venrock Associates. RUSNANO will invest up to $40 million and Sequoia Capital Growth Fund will contribute $20 million, [...]

Russian state technology firm Rusnano is teaming up with a US venture fund, writes Reuters. Rusnano and life sciences technologies investor Domain Associates are planning to co-invest in about 20 US-based healthcare technology companies. Rusnano will invest up to $330 million and Domain’s venture capital funds and other investors will invest a like amount, according [...]

Watertown, Mass.-based Selecta Biosciences Inc. has closed on up to $47.25 million financing round from investors including RUSNANO, a $10-billion Russian Federation fund. The funding will be used for research and development efforts around the company’s vaccines and immunotherapies. Selecta’s financing breaks down into a $22 million Series D, and additional funding up to $25.25 million for strategic activities in Russia, the company said.